NICE launches its Medtech Early Technical Assessment (META) tool

The Scientific Advice service at NICE are to launch an online tool which has been designed to help developers of medical devices and diagnostics understand and generate the evidence needed to demonstrate that their products are clinically and cost effective. The Medtech Early Technical Assessment (META) tool will help companies prepare for a dialogue with health technology assessment organisations and payers to facilitate market access. The tool is designed to help companies identify where there are gaps in their evidence, which would need to be filled in order to satisfy payer requirements.
Leeza Osipenko, head of NICE Scientific Advice said: “Medical devices and diagnostics is a fast growing and highly competitive field. Healthcare systems are facing financial pressures and are keen to adopt transformative and cost saving technologies. We want to help healthcare systems get access to more products that meet such criteria and help companies develop these technologies and relevant evidence to demonstrate their value to patients and payers… we’ve designed META to ensure it’s both affordable and flexible.”

The META tool can be licensed for use by partner organisations working with medtech companies, and MAP MedTech has been selected by NICE to become one of the first partner organisations trained to use the tool.

To read more about this, please click here.

Tagged with

Published on 31. May 2017 in News UK